Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Shares Issued (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Shares Issued for 5 consecutive years, with $17000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Issued changed N/A year-over-year to $17000.0, compared with a TTM value of $19000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $19000.0, changed N/A over the prior year.
  • Shares Issued was $17000.0 for Q2 2025 at aTYR PHARMA, up from $2000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $6.4 million in Q1 2021 and bottomed at -$15.2 million in Q2 2021.
  • Average Shares Issued over 3 years is -$1.1 million, with a median of $10000.0 recorded in 2021.
  • Peak annual rise in Shares Issued hit 113.33% in 2021, while the deepest fall reached 424.1% in 2021.
  • Year by year, Shares Issued stood at $3000.0 in 2021, then plummeted by 50066.67% to -$1.5 million in 2022, then surged by 101.13% to $17000.0 in 2025.
  • Business Quant data shows Shares Issued for ATYR at $17000.0 in Q2 2025, $2000.0 in Q1 2025, and -$1.5 million in Q2 2022.